Ahn Tae Kyu, Kang Soo, Paik Jin Hui, Seo Young Ho
Department of Emergency Medicine, Inha University School of Medicine, Incheon, Korea.
Clin Exp Emerg Med. 2021 Sep;8(3):153-159. doi: 10.15441/ceem.21.067. Epub 2021 Sep 30.
The coronavirus disease 2019 (COVID-19) vaccines are categorized according to the manufacturing technique, including mRNA vaccines and adenovirus vector vaccines. According to previous studies, the reported efficacy of the COVID-19 vaccine is excellent regardless of the type of vaccine, and the majority of studies have shown similar results for safety. Most of the adverse reactions after vaccination were mild or moderate grade, and severe reactions were reported in a very small proportion. However, the adverse reactions that might occur after nationwide vaccinations can contribute to crowding of emergency departments, and this can further lead to significant obstacles to providing necessary treatment for life-threatening conditions. Therefore, as emergency physicians, we would like to present some concerns and suggestions to prevent these predictable problems.
2019冠状病毒病(COVID-19)疫苗根据生产技术进行分类,包括信使核糖核酸(mRNA)疫苗和腺病毒载体疫苗。根据以往研究,无论疫苗类型如何,所报道的COVID-19疫苗效力都很出色,并且大多数研究表明在安全性方面也有类似结果。接种疫苗后的不良反应大多为轻度或中度,严重反应的报告比例非常小。然而,全国范围接种疫苗后可能出现的不良反应会导致急诊科人满为患,进而可能给危及生命状况的必要治疗造成重大障碍。因此,作为急诊医生,我们想提出一些担忧和建议以预防这些可预见的问题。